• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameTRUFILL N-BUTYL CYANOACRYLATE (N-BCA) LIQUID EMBOLIC SYSTEM
Classification Nametissue adhesive for use in embolization of brain arteriovenous malformations
Generic Nameartificial embolization device
ApplicantCODMAN & SHURTLEFF, INC.
PMA NumberP990040
Supplement NumberS007
Date Received01/07/2009
Decision Date02/06/2009
Product Code
KGG[ Registered Establishments with KGG ]
Advisory Committee General & Plastic Surgery
Supplement Type30-day notice
Supplement Reason process change: manufacturing
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Changes and modifications as follows: 1) the transfer of the manufacturing of the trufill n-bca liquid embolic system from one building to another within the same facility; 2) a clarification of the instructions for use (1fu) the removal of a redundant incoming receiving inspection for the n-bca and tantalum pouch; 3) the removal of a specification for the n-bca and tantalum pouch; and 4) modification of the seal specifications for the n-bca and tantalum pouch.
-
-